8legs: Nhs england

Your Followed Topics

#1 out of 4

Latest data show most NHS trusts failed to meet the 85% 62-day cancer wait target in 2025.
A small number of trusts did meet the 85% target, led by Calderdale and Huddersfield, Homerton Healthcare, and Maidstone & Tunbridge Wells.
Some trusts reported 104-day waits from urgent referral, signaling severe delays in cancer pathways.
Cancer Research UK cautions that every patient deserves timely, high-quality care amid rising pressures.
England aims to meet waiting time standards by 2029, but current progress lags behind.
Some NHS trusts reported improvements and ended 2025 above 75% within 62 days.
Cancer waiting times data are used to gauge survival chances and patient anxiety.
NHS officials defend care as record numbers are diagnosed each year, but delays persist.
Think tank and experts call for investments in workforce and equipment to improve cancer care.
NHS plans include a National Cancer Plan to improve on-time access and survival.

Vote 0

#2 out of 40.00%

The NHS secured two clinically assured alternatives to the main bone cement supplier to avoid surgery delays.
A packaging fault at Heraeus Medical disrupted bone cement production and threatened two months of supply.
Hospitals were told to prioritise urgent cases to manage the limited stock.
NHS Supply Chain named Zimmer Biomet High Fatigue G and Johnson & Johnson CMW Smartset GHV Gentamicin as alternatives.
Professor Tim Briggs said the rescue package helps ensure ongoing trauma and elective care.
The shortage risked delays to hip and knee replacements and other planned procedures.
Two weeks of stock remained before the gap widened to six to eight weeks.
The update came from NHS England and NHS Supply Chain.
The incident prompted NHS England to call for prioritisation of urgent clinical needs.
The NHS described the arrangement as a 'rescue package' to keep care on track.

Vote 0

#3 out of 4

NHS England approves ruxolitinib cream to treat vitiligo, enabling color restoration for many patients.
Up to about 100,000 UK residents aged 12+ with vitiligo may access the new NHS treatment.
Clinical trials show many patients achieve at least 75% skin colour restoration on the face after six months.
Vitiligo patches appear due to autoimmune damage to pigment-producing cells called melanocytes.
Treatment aims to calm the immune attack rather than merely camouflage patches.
The NHS previously rejected the drug before rapid review and negotiations cleared its rollout.
Vitiligo affects about one in 100 people worldwide and can impact mental health when visible on the face.
Ruxolitinib dampens immune signals to allow recovery of pigment cells.
Famous vitiligo sufferers like Winnie Harlow are cited as context for the treatment's impact.
The NHS aims to provide new options beyond camouflage and light therapy.

Vote 0

#4 out of 4

health10h ago

In 2025, only three NHS trusts met the 85% 62-day cancer wait target, underscoring widespread delays.
Nationally, 69.1% of patients began cancer treatment within 62 days in 2025, up slightly but well below the target.
Some trusts reported long delays, with more than 104 days for a notable share of patients after urgent referrals.
Health groups warn ongoing gaps require continued momentum and investment to reach targets by 2029.
NHS says it is treating record numbers of cancer patients and aims for faster diagnosis and treatment.
Analysts note only a few trusts improved year over year on 62-day performance in 2025.
Nuffield Trust cautions against stagnation as trusts push toward the 85% target.
Some trusts showed notable variations, with several performing notably below 60% within 62 days.
Officials emphasize a National Cancer Plan to improve timely care over the next three years.
The analysis compares 2025 data with 2024 figures to show progress and gaps.
The report highlights a wide variation among trusts in England in cancer waiting times.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.